Intel (INTC) is trading at a new two-year high. Shares are up a whopping 145% over the past 52 weeks. INTC maintains a 100% technical “Buy” opinion from Barchart. The stock hit new highs coming out...
/A%20close-up%20shot%20of%20the%20Taiwan%20Semi%20logo%20on%20a%20corporate%20building%20by%20Jack%20Hong%20via%20Shutterstock.jpg)
Taiwan Semiconductor (TSM) shares are trading at new all-time highs. Shares are up nearly 70% over the past 52 weeks. TSM maintains a 100% technical “Buy” opinion from Barchart. The stock hit new highs...
/Computer%20board%20micro%20chip%20green%20by%20blickpixel%20via%20Pixabay.jpg){kind=tracking}
Sandisk (SNDK) is trading at new all-time highs. Shares are up more than 745% over the past six months. SNDK maintains a 100% “Buy” technical opinion from Barchart. The stock is benefitting from what...
Rocket Companies (RKT) is trading at new three-year highs. Shares are up more than 125% over the past year, and 25% in just the last month. RKT maintains a 100% “Buy” opinion from Barchart. The stock...
Alamos Gold (AGI) is trading at a new all-time high on Monday, and shares are up more than 118% over the past 52 weeks. AGI is benefiting from gold (GCG26) hitting new record highs on Monday. Some experts...
Daily Journal (DJCO) is trading at new a 52-week high and has strong technical momentum. Shares are up nearly 25% in the past month. DJCO maintains a 100% “Buy” technical opinion from Barchart. Some...
Troops (TROO) has surged 179% since a Trend Seeker “Buy” signal was issued on Dec. 8. Shares are up nearly 140% over the past 52 weeks. Despite the run-up, Morningstar estimates that TROO remains 44%...
Amneal Pharmaceuticals (AMRX) is trading at new 5-year highs with strong technical momentum. AMRX has gained 69% over the past year. Shares maintain a 100% “Buy” technical opinion on Barchart. Analyst...
Vodafone (VOD) is trading at a new 3-year high and has strong technical momentum. Shares are up nearly 61% over the past 52 weeks. VOD maintains a 100% “Buy” technical rating from Barchart. Some analysts...
vTv Therapeutics (VTVT) is a $156 million biopharma focused on small molecule drugs for Alzheimer’s, diabetes, and inflammatory disorders, all in clinical trials. VTVT has surged 182% over the past year,...